Publisher： Bentham Science Publishers
E-ISSN： 2212-3938|6|3|214-221
ISSN： 1574-8847
Source： Current Clinical Pharmacology, Vol.6, Iss.3, 2011-08, pp. : 214-221
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dual Inhibition of PI3-Kinase and mTOR in Renal Cell Carcinoma
Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. :
Access to resources
Recommend
The Applicability of mTOR Inhibition in Solid Tumors
Current Cancer Drug Targets, Vol. 9, Iss. 3, 2009-05 ,pp. :
mTOR Inhibition in Lymphoma: A Rational and Promising Strategy
Letters in Drug Design & Discovery, Vol. 4, Iss. 3, 2007-04 ,pp. :